Diseased Human Peripheral Blood Products, Bladder Cancer

Primary human cells, fresh or frozen

New label, same high-quality cancer PBMCs! The product label for Cancer Peripheral Blood Mononuclear Cells, Frozen has been updated from “Full Collection” to “5-19 million cells” to more accurately reflect the cell number provided (in millions). As the product itself and manufacturing procedures have not changed, some inventory with the old name will be shipped during the transition period. For each collection, the measured cell count prior to cryopreservation will be listed on the Certificate of Analysis (CoA).

Diseased Human Peripheral Blood Products, Bladder Cancer

Primary human cells, fresh or frozen

Catalog #
(Select a product)
Primary human cells, fresh or frozen
Request Pricing
Add to Wish List

Overview

Start immuno-oncology experiments confidently with a reliable supply of ethically sourced, fresh and frozen peripheral blood products from donors diagnosed with bladder cancer. Options include cancer-sourced whole blood, one-tenth leukopaks, frozen peripheral blood mononuclear cells (MNCs or PBMCs), and custom-isolated frozen products such as plasma and serum. We help you get the cells you need with personalized service and flexible delivery times.

Cancer-sourced leukopaks are an enriched leukapheresis product consisting of a large number of single-donor MNCs. Primary human MNCs are isolated from peripheral blood, leukapheresis, or whole blood samples using density gradient separation or red blood cell lysis and cryopreserved in animal component-free CryoStor® CS10 medium. All fresh and frozen peripheral blood products are obtained from donors diagnosed with bladder cancer using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements is available upon request. Sodium heparin (Na-Hep), ethylenediaminetetraacetic acid (EDTA), or acid-citrate-dextrose solution A (ACDA) is added during collection as an anticoagulant.

Contact techsupport@stemcell.com if high-resolution HLA typing (Class I and Class II alleles and CMV status) is required or for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories. For more information, browse frequently asked questions (FAQs) on primary cells.
Contains
CryoStor® CS10
Subtype
Fresh, Frozen
Cell Type
Leukopaks, Mononuclear Cells, Whole
Species
Human
Cell and Tissue Source
Peripheral Blood, Plasma, Serum
Area of Interest
Cancer

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
200-0290
Lot #
All
Language
English
Catalog #
200-0228
Lot #
All
Language
English
Catalog #
200-0434
Lot #
Lot# 230281101C or higher
Language
English
Catalog #
200-0434
Lot #
Lot# 230181101C or lower
Language
English
Catalog #
200-0275
Lot #
All
Language
English
Catalog #
200-0260
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Research Area
Workflow Stages
Workflow Stages for Genome Editing
New label, same high-quality cancer PBMCs! The product label for Cancer Peripheral Blood Mononuclear Cells, Frozen has been updated from “Full Collection” to “5-19 million cells” to more accurately reflect the cell number provided (in millions). As the product itself and manufacturing procedures have not changed, some inventory with the old name will be shipped during the transition period. For each collection, the measured cell count prior to cryopreservation will be listed on the Certificate of Analysis (CoA).